cor2ed
engage checkpoint medical linkedin twitter
bg

An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr. Shinji Ohno, Dr. Rebecca Dent, Prof. Charlie Gourley

DDR and PARPi Expert Forums were held with international faculty in Tokyo and Singapore during January 2020.
Portrait of Keiichi Fujiwara
Prof. Keiichi Fujiwara

Gynaecologic Oncologist

Saitama Medical University International Medical Center

Japan

Portrait of Simon Boulton
Prof. Simon Boulton

Senior Scientist

Francis Crick Institute

United Kingdom (UK)

Portrait of Shinji Ohno
Dr. Shinji Ohno

Medical Oncologist

Cancer Institute Hospital of JFCR

Japan

Portrait of Rebecca Dent
Dr. Rebecca Dent

Medical Oncologist

National Cancer Center Singapore

Singapore

Portrait of Charlie Gourley
Prof. Charlie Gourley

Medical Oncologist

CRUK Edinburgh Centre, Nicola Murray Centre for Ovarian Cancer Re...

United Kingdom (UK)

preview next

time | open 60 min

temporal

download resources

I agree that this educational programme:

Was valuable to me:

1/3

Learn about the role of PARP inhibitors in clinical practice and targeting DDR, including:

  • Mechanism of Action of PARP inhibition and targeting DDR

  • Clinical profile of PARP inhibitors and their benefit in ovarian and breast cancer

  • Appropriate patient selection for PARP inhibition

  • Future DDR and PARP inhibition

Other programmes of interest

Other programmes developed by Prof. Simon Boulton

Other programmes developed by Dr. Rebecca Dent

Other programmes developed by Prof. Charlie Gourley